Similar articles

• [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].

  Weirich EG, Lutz U. Weirich EG, et al. Dermatologica. 1973;147(6):353-75. Dermatologica. 1973. PMID: 4788215 Clinical Trial. German. No abstract available.
• [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].

  Zaun H, Altmeyer P. Zaun H, et al. Arch Dermatol Forsch. 1973;247(4):379-86. Arch Dermatol Forsch. 1973. PMID: 4767633 German. No abstract available.
• Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.

  Smith EB, Gregory JF, Bartruff JK. Smith EB, et al. South Med J. 1973 Mar;66(3):325-9. doi: 10.1097/00007611-197303000-00011. South Med J. 1973. PMID: 4570656 Clinical Trial. No abstract available.
• Heterogeneity of glucocorticoid receptors.

  Funder JW, Barlow JW. Funder JW, et al. Circ Res. 1980 Jun;46(6 Pt 2):I83-7. Circ Res. 1980. PMID: 6247099 Review. No abstract available.
• Anaphylaxis induced by the carboxymethylcellulose component of injectable triamcinolone acetonide suspension (Kenalog).

  Patterson DL, Yunginger JW, Dunn WF, Jones RT, Hunt LW. Patterson DL, et al. Ann Allergy Asthma Immunol. 1995 Feb;74(2):163-6. Ann Allergy Asthma Immunol. 1995. PMID: 7697477 Review.